Nancy U Lin

55PUBLICATIONS

368CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisInnate immunityRadiation therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (55)

Sort by Publication Date:

|Jun 05, 2026

Longitudinal multi-platform profiling reveals temporal dynamics of HER2, TROP2, PD-L1 and tumor-infiltrating lymphocytes in triple-negative breast cancer.

|May 15, 2026

Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial.

|May 11, 2026

Invest where impact begins: recommendations from Breast Cancer Research Foundation Early Career Investigator Working Group (Part 1 of 2).

|Mar 19, 2026

Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2<sup>+</sup> breast cancer: TBCRC049 phase 2 study results.

Rashmi K Murthy, Barbara J O'Brien, Donald A Berry

|Mar 07, 2026

A phase II study of atezolizumab in combination with stereotactic radiation for patients with triple-negative breast cancer and brain metastasis.

Antonio Giordano, Noah Graham, Ayal A Aizer

|Nov 21, 2025

Multimodal Artificial Intelligence Model From Baseline Histopathology Adds Prognostic Information for Distant Recurrence Assessment in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Daniel Kates-Harbeck, Hans Kreipe, Oleg Gluz

Pageof 10

Frequent Collaborators

13 joint publications

Sara M Tolaney

13 joint publications

Eric Winer

Elizabeth Mittendorf

Ian E Krop

Nabihah Tayob

Ana Garrido-Castro

Lisa A Carey

Judy Garber

Nikhil Wagle

Romualdo Barroso-Sousa

Frequent Collaborators

13 joint publications

Sara M Tolaney

13 joint publications

Eric Winer

9 joint publications

Elizabeth Mittendorf

6 joint publications

Ian E Krop